JPWO2022246154A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022246154A5 JPWO2022246154A5 JP2023571586A JP2023571586A JPWO2022246154A5 JP WO2022246154 A5 JPWO2022246154 A5 JP WO2022246154A5 JP 2023571586 A JP2023571586 A JP 2023571586A JP 2023571586 A JP2023571586 A JP 2023571586A JP WO2022246154 A5 JPWO2022246154 A5 JP WO2022246154A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163201952P | 2021-05-20 | 2021-05-20 | |
| US63/201,952 | 2021-05-20 | ||
| PCT/US2022/030189 WO2022246154A2 (en) | 2021-05-20 | 2022-05-20 | Antibodies that bind to c1s and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024518844A JP2024518844A (ja) | 2024-05-07 |
| JP2024518844A5 JP2024518844A5 (https=) | 2025-05-28 |
| JPWO2022246154A5 true JPWO2022246154A5 (https=) | 2025-05-28 |
Family
ID=84141843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571586A Pending JP2024518844A (ja) | 2021-05-20 | 2022-05-20 | Ｃ１ｓに結合する抗体およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12252550B2 (https=) |
| EP (1) | EP4340879A4 (https=) |
| JP (1) | JP2024518844A (https=) |
| CN (1) | CN117769434A (https=) |
| WO (1) | WO2022246154A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023385709A1 (en) | 2022-11-21 | 2025-06-12 | Dianthus Therapeutics Opco, Inc. | Antibodies that bind to c1s and uses thereof |
| AU2024237478A1 (en) | 2023-03-16 | 2025-10-30 | Genzyme Corporation | Treatment of dry age-related macular degeneration |
| US20250206814A1 (en) * | 2023-12-20 | 2025-06-26 | Dianthus Therapeutics Opco, Inc. | Pharmaceutical compositions comprising antibodies for treatment of c1s mediated disorders and methods of using the same |
| WO2025129535A1 (en) * | 2023-12-20 | 2025-06-26 | Dianthus Therapeutics Opco, Inc. | Pharmaceutical compositions comprising antibodies for treatment of c1s mediated disorders and methods of using the same |
| TW202547886A (zh) * | 2024-02-02 | 2025-12-16 | 美商黛安瑟斯醫療運營公司 | 用於治療ｃ１ｓ介導的疾病和病症的組成物、劑量和方法 |
| US20250376511A1 (en) | 2024-06-05 | 2025-12-11 | Genzyme Corporation | BINDING PROTEINS THAT TARGET aC1s, TfR, OR BOTH, AND COMPOSITIONS THEREOF |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| ATE87659T1 (de) | 1986-09-02 | 1993-04-15 | Enzon Lab Inc | Bindungsmolekuele mit einzelpolypeptidkette. |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| DE69232137T2 (de) | 1991-11-25 | 2002-05-29 | Enzon Inc | Multivalente antigen-bindende proteine |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| AU701578B2 (en) | 1992-08-21 | 1999-02-04 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| US6005079A (en) | 1992-08-21 | 1999-12-21 | Vrije Universiteit Brussels | Immunoglobulins devoid of light chains |
| WO1994025591A1 (en) | 1993-04-29 | 1994-11-10 | Unilever N.V. | PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE) |
| GB9818110D0 (en) | 1998-08-19 | 1998-10-14 | Weston Medical Ltd | Needleless injectors and other devices |
| US6096002A (en) | 1998-11-18 | 2000-08-01 | Bioject, Inc. | NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method |
| PT1355919E (pt) | 2000-12-12 | 2011-03-02 | Medimmune Llc | Moléculas com semivida longa, composições que as contêm e suas utilizações |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| PT3415619T (pt) * | 2011-04-28 | 2021-03-22 | Univ Leland Stanford Junior | Identificação de polinucleótidos associados a uma amostra |
| DK2914291T3 (da) * | 2012-11-02 | 2022-05-16 | Bioverativ Usa Inc | Anti-komplement-c1s-antistoffer og anvendelser deraf |
| EP2996722A4 (en) | 2013-05-15 | 2017-01-11 | Annexon, Inc. | Methods of treatment for guillain-barre syndrome |
| KR20160068855A (ko) * | 2013-10-11 | 2016-06-15 | 제넨테크, 인크. | Nsp4 억제제 및 사용 방법 |
| WO2016164358A1 (en) * | 2015-04-06 | 2016-10-13 | True North Therapeutics, Inc. | Humanized anti-c1s antibodies and methods of use thereof |
| CN106939047B (zh) * | 2016-01-04 | 2021-08-31 | 江苏怀瑜药业有限公司 | 一种pd-l1抗体及其制备方法 |
| HUE073475T2 (hu) | 2016-10-12 | 2026-01-28 | Bioverativ Usa Inc | C1s elleni antitestek és alkalmazási eljárásaik |
| TWI780083B (zh) | 2016-11-18 | 2022-10-11 | 丹麥商賽門弗鎮公司 | 抗pd-1抗體及組成物 |
| CA3055781A1 (en) | 2017-03-14 | 2018-09-20 | Bioverativ Usa Inc. | Methods for treating complement-mediated diseases and disorders |
| EP3710589A4 (en) * | 2017-11-14 | 2021-11-10 | Chugai Seiyaku Kabushiki Kaisha | ANTI-C1S ANTIBODIES AND METHOD OF USING |
| WO2022046888A1 (en) | 2020-08-25 | 2022-03-03 | Target Discovery Merger Sub II, LLC | Sars-cov-2 associated antibody compositions and methods of use |
-
2022
- 2022-05-20 CN CN202280048661.4A patent/CN117769434A/zh active Pending
- 2022-05-20 US US17/749,362 patent/US12252550B2/en active Active
- 2022-05-20 JP JP2023571586A patent/JP2024518844A/ja active Pending
- 2022-05-20 WO PCT/US2022/030189 patent/WO2022246154A2/en not_active Ceased
- 2022-05-20 EP EP22805547.1A patent/EP4340879A4/en active Pending
-
2025
- 2025-02-07 US US19/047,877 patent/US20260022195A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI757304B (zh) | Lag-3抗體、其抗原結合片段及其醫藥用途 | |
| JP2024150751A5 (https=) | ||
| JP7600328B2 (ja) | ＰＤ－１とＴＧＦ－ｂｅｔａを標的とした四価二重特異性抗体、その製造方法および用途 | |
| CN115397852B (zh) | 工程化抗il-2抗体 | |
| KR20230113348A (ko) | 항 ＳＩＲＰα 항체 및 이의 용도 | |
| US20110044996A1 (en) | Neutralizing antibodies | |
| KR20180006369A (ko) | Cd47에 결합하는 항체 치료제 | |
| CN107922484A (zh) | 结合tim3的抗体治疗剂 | |
| WO2022105914A1 (zh) | Cd70抗体及其应用 | |
| CN113150156B (zh) | 抗tigit抗体及其用途 | |
| TW202233674A (zh) | 用於調節δγ鏈介導之免疫的組成物及方法 | |
| CN113795510A (zh) | 抗pd-l1抗体及其应用 | |
| WO2014072741A1 (en) | Humanised antibody and method of production thereof | |
| WO2022218380A1 (zh) | 靶向bcma的多特异性抗体 | |
| RU2019121106A (ru) | Иммунотерапия с применением антител, связывающих белок 1 программируемой смерти клеток (pd-1) | |
| CN106574259A (zh) | 新的抗人类Igβ抗体 | |
| US20100297135A1 (en) | Epitope for neutralizing antibodies | |
| JPWO2022246154A5 (https=) | ||
| JP2019518473A5 (https=) | ||
| WO2022188801A1 (zh) | Pd-1结合蛋白及其医药用途 | |
| JPWO2020234399A5 (https=) | ||
| US20260035463A1 (en) | Multispecific antibody and use thereof | |
| JPWO2022226342A5 (https=) | ||
| JPWO2021020846A5 (https=) | ||
| WO2024041639A1 (en) | Antibodies targeting tigit and uses thereof |